Literature DB >> 14507606

Longitudinal patterns of drug injection behavior in the ALIVE Study cohort,1988-2000: description and determinants.

N Galai1, M Safaeian, D Vlahov, A Bolotin, D D Celentano.   

Abstract

The objective of this study was to characterize longitudinal patterns of drug injection behavior for individuals and to identify their early determinants. Participants were 1,339 injection drug users recruited into the AIDS Link to Intravenous Experience (ALIVE) Study in Baltimore, Maryland, through community outreach efforts. The study was initiated in 1988, and follow-up continued through 2000, with semiannual visits. Patterns of self-reported drug injection (yes/no) were defined for each participant, based on the number of drug-use transitions. The effect of baseline factors was assessed using multinomial logistic regression models. Over the 12-year study period, four patterns were noted: 29% of participants remained persistent drug injectors, 20% ceased injection, 14% relapsed once, and 37% had multiple transitions. Persistent injectors had the shortest follow-up and the highest mortality. For persons who changed their behavior, 3.4 years elapsed before their first cessation attempt, on average. Factors differentiating the groups included history of incarceration, young age, participation in drug treatment programs, recent overdose, and commercial sex. The observed long-term injection patterns are consistent with the view of drug addiction as a chronic disease. This view emphasizes the need for prolonged efforts to sustain cessation and to prevent adverse health and social outcomes among injection drug users.

Entities:  

Mesh:

Year:  2003        PMID: 14507606     DOI: 10.1093/aje/kwg209

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  75 in total

1.  Maintenance of reinforcement to address the chronic nature of drug addiction.

Authors:  Kenneth Silverman; Anthony DeFulio; Sigurdur O Sigurdsson
Journal:  Prev Med       Date:  2012-06-05       Impact factor: 4.018

2.  Exploring the limits and utility of operant conditioning in the treatment of drug addiction.

Authors:  Kenneth Silverman
Journal:  Behav Anal       Date:  2004

3.  Impact of interim methadone maintenance on HIV risk behaviors.

Authors:  Monique E Wilson; Robert P Schwartz; Kevin E O'Grady; Jerome H Jaffe
Journal:  J Urban Health       Date:  2010-07       Impact factor: 3.671

4.  Predictors of Injection Cessation and Relapse among Female Sex Workers who Inject Drugs in Two Mexican-US Border Cities.

Authors:  Brooke S West; Daniela Abramovitz; Hugo Staines; Alicia Vera; Thomas L Patterson; Steffanie A Strathdee
Journal:  J Urban Health       Date:  2016-02       Impact factor: 3.671

5.  Cessation of injecting drug use among street-based youth.

Authors:  Colin Steensma; Jean-François Boivin; Lucie Blais; Elise Roy
Journal:  J Urban Health       Date:  2005-09-29       Impact factor: 3.671

6.  Tobacco use and nicotine dependence among HIV-infected and uninfected injection drug users.

Authors:  Mariah M Marshall; Gregory D Kirk; Neil E Caporaso; Meredith C McCormack; Christian A Merlo; John C Hague; Shruti H Mehta; Eric A Engels
Journal:  Addict Behav       Date:  2010-09-26       Impact factor: 3.913

7.  A prospective study of alcohol consumption and HIV acquisition among injection drug users.

Authors:  Chanelle J Howe; Stephen R Cole; David G Ostrow; Shruti H Mehta; Gregory D Kirk
Journal:  AIDS       Date:  2011-01-14       Impact factor: 4.177

8.  Correlates of syringe coverage for heroin injection in 35 large metropolitan areas in the US in which heroin is the dominant injected drug.

Authors:  Barbara Tempalski; Hannah L Cooper; Samuel R Friedman; Don C Des Jarlais; Joanne Brady; Karla Gostnell
Journal:  Int J Drug Policy       Date:  2008-03-04

9.  Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.

Authors:  Keri L Calkins; Catherine R Lesko; Geetanjali Chander; Richard D Moore; Bryan Lau
Journal:  J Acquir Immune Defic Syndr       Date:  2018-03-01       Impact factor: 3.731

10.  Supervised Injection Facility Utilization Patterns: A Prospective Cohort Study in Vancouver, Canada.

Authors:  Mary Clare Kennedy; David C Klassen; Huiru Dong; M-J S Milloy; Kanna Hayashi; Thomas H Kerr
Journal:  Am J Prev Med       Date:  2019-08-01       Impact factor: 5.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.